Lumiliximab
Lumiliximab (Anti-CD23 Recombinant Antibody) is an anti-CD23 monoclonal antibody that inhibits allergen-induced responses[1].
Product Specifications
CAS Number
[357613-86-6]
Product Name Alternative
Gomiliximab; IDEC-152; ST-152
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/lumiliximab.html
Purity
99.82
Solubility
H2O
Smiles
[Lumiliximab]
Molecular Weight
(144.82 kDa)
References & Citations
[1]Poole JA, et al. Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects. J Allergy Clin Immunol. 2005 Oct;116 (4) :780-8.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS9922047-03 5x 96 Well
Bovine G Protein-Coupled Receptor Kinase 4 (GRK4) ELISA Kit
Ask
View Details 
MBS9922047-04 10x 96 Well
Bovine G Protein-Coupled Receptor Kinase 4 (GRK4) ELISA Kit
Ask
View Details